📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. (2018)

First Author: CRyPTIC Consortium And The 100,000 Genomes Project

Attributed to: Comprehensive Resistance Prediction for Tuberculosis: an International Consortium (CRyPTIC) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1800474

PubMed Identifier: 30280646

Publication URI: http://europepmc.org/abstract/MED/30280646

Type: Journal Article/Review

Volume: 379

Parent Publication: The New England journal of medicine

Issue: 15

ISSN: 0028-4793